Results 151 to 160 of about 4,608 (197)

Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE and Monitoring with Somatostatin Receptor PET/CT in Patients with Advanced Differentiated Thyroid Carcinoma. [PDF]

Mol Imaging Biol
Kunte SC, Wenter VU, Holzgreve A, Sheikh GT, Widjaja L, Gildehaus FJ, Lindner S, Schirrmacher R, Spitzweg C, Auernhammer CJ, Werner RA, Zacherl MJ.   +11 more
europepmc   +1 more source

Lutetium-177 DOTATATE for the Treatment of Esthesioneuroblastoma: A Case Report. [PDF]

Case Rep Oncol Med
Avila-Rodriguez V, Wagner-Gutiérrez N, Jacobo J, Pineda D, Gonzalez A, Aristizabal J, Bobadilla I, Sánchez N, Zuluaga JA, Cardona AF.   +9 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. [PDF]

Cancers (Basel)
Perrone E, Calcagni ML, Leccisotti L, Moretti R, Ghai K, Eismant A, Parkar T, Greifenstein L, Baum RP.   +8 more
europepmc   +1 more source

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE

, 2019
Christoph Wetz, Philipp Genseke, Ivayla Apostolova, Christian Furth, Sammy Ghazzawi, Julian M.M. Rogasch, Imke Schatka, Michael C. Kreißl, Frank Hofheinz, Oliver S. Großer, Holger Amthauer   +10 more
openalex   +2 more sources

The therapeutic efficacy of ²²⁵Ac-DOTATATE in neuroendocrine tumors: a preliminary meta-analysis. [PDF]

Front Oncol
Ma J, Ji Y, Yao Z, Yangqing J, Zhang C.
europepmc   +1 more source

Contrast-Enhanced Ultrasound and Somatostatin Receptor Scintigraphy Unveil an Occult Neuroendocrine Tumor With Carcinoid Syndrome and Presumed Small Intestinal Origin - A Case Report. [PDF]

Gastro Hep Adv
Sato T, Nishio A, Kegasawa T, Hazu K, Tarumi C, Yamada K, Nishiura Y, Higashihara K, Nagahama S, Matsumae T, Tokuda Y, Ishimi A, Hiyama S, Ogata M, Nakai C, Masuko K, Yamamoto K, Tatsumi N, Yoshida Y, Isohashi K, Hayashi Y, Kaneko A.   +21 more
europepmc   +1 more source

Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
AlQahtani MS, Miutescu B, Domilescu I, Negru S, Popovici D, Gadour E.   +5 more
europepmc   +1 more source

Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT. [PDF]

Cancers (Basel)
Chauhan A, Halfdanarson TR, Vijayvergia N.   +2 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy-Induced Hypercortisolemic Crisis in Ectopic Cushing Syndrome. [PDF]

JCEM Case Rep
Pandit R, Yamichannaiah C, Lila AR, Karlekar M, Memon SS, Bandgar T.   +5 more
europepmc   +1 more source